Skip to main content
    C

    Cullinan Oncology LLC (CGEM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.50
    -0.78 (-7.59%)

    Market Cap: $667.39M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cullinan Oncology LLC (CGEM) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Cullinan Oncology LLC (CGEM) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Cullinan Oncology LLC reported EPS of -$0.74, above the -$0.79 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    63%(15/24)
    Avg Surprise
    -28.51%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.84
    Range-$1.14 - -$0.38
    15 analysts
    Revenue Consensus
    $15.43M
    RangeN/A
    13 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.59
    Range-$0.99 - -$0.35
    3 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.86+31.6%
    60d ago-$0.86+31.6%
    30d ago-$0.83+28.6%
    7d ago-$0.76+22.3%
    Current-$0.59
    Revenue Consensus
    $20.33M
    RangeN/A
    3 analysts

    Next Report

    CGEM has an expected report date of Mar 8, 2027.

    Earnings History

    Of the 24 quarters below that had an estimate, CGEM beat 15 and missed 9. The widest gap in the table came in the quarter ended Dec 31, 2020, when EPS landed 652.63% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.74-$0.79-$1.04 - -$0.71+6.33%BeatN/A92 up, 0 downNov 10, 2026
    Jun 30, 2026-$0.81-$0.71N/A-14.08%MissN/A92 up, 1 downAug 6, 2026
    Mar 31, 2026-$0.75-$0.84-$0.93 - -$0.75+10.71%BeatN/A81 up, 0 downMay 7, 2026
    Dec 31, 2025-$0.77-$0.87-$0.99 - -$0.49+11.89%BeatN/A92 up, 1 downMar 10, 2026
    Sep 30, 2025-$0.77-$0.89-$0.98 - -$0.81+13.48%BeatN/A81 up, 5 downNov 6, 2025
    Jun 30, 2025-$1.07-$0.83-$1.14 - -$0.71-28.92%MissN/A72 up, 2 downAug 7, 2025
    Mar 31, 2025-$0.74-$0.81-$0.90 - -$0.75+8.64%BeatN/A71 up, 0 downMay 8, 2025
    Dec 31, 2024-$0.73-$0.74-$0.94 - -$0.60+1.66%BeatN/A81 up, 0 downFeb 27, 2025
    Sep 30, 2024-$0.69-$0.77-$0.99 - -$0.69+10.39%BeatN/A100 up, 0 downNov 7, 2024
    Jun 30, 2024-$0.75-$0.73-$0.89 - -$0.62-2.74%MissN/A90 up, 0 downAug 8, 2024
    Mar 31, 2024-$0.86-$0.99-$1.42 - -$0.72+13.13%BeatN/A91 up, 0 downMay 15, 2024
    Dec 31, 2023-$0.54-$0.98-$1.00 - -$0.91+44.90%BeatN/A70 up, 0 downMar 14, 2024
    Sep 30, 2023-$0.91-$0.94-$1.07 - -$0.82+3.19%BeatN/A60 up, 0 downNov 8, 2023
    Jun 30, 2023-$0.82-$1.00-$1.31 - -$0.85+18.00%Beat-121.8%50 up, 0 downAug 10, 2023
    Mar 31, 2023-$1.42-$0.98-$1.39 - -$0.59-44.90%MissN/A40 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.59-$0.71-$0.87 - -$0.48+16.90%BeatN/A40 up, 0 downMar 9, 2023
    Sep 30, 2022-$0.54-$0.97-$1.50 - -$0.63+44.33%BeatN/A30 up, 0 downNov 14, 2022
    Jun 30, 2022$3.77$5.42$5.40 - $5.44-30.44%MissN/A30 up, 0 downAug 10, 2022
    Mar 31, 2022-$0.27-$0.55N/A+50.91%BeatN/A30 up, 0 downMay 16, 2022
    Dec 31, 2021-$0.74-$0.47-$0.54 - -$0.44-57.45%MissN/A30 up, 0 downMar 17, 2022
    Sep 30, 2021-$0.50-$0.43N/A-16.28%MissN/A22 up, 0 downNov 9, 2021
    Jun 30, 2021-$0.36-$0.42-$0.42 - -$0.41+14.29%BeatN/A2N/AAug 10, 2021
    Mar 31, 2021$0.00$0.03$0.03 - $0.10-105.67%MissN/A2N/AMay 14, 2021
    Dec 31, 2020-$2.86-$0.38-$0.48 - -$0.29-652.63%MissN/A2N/AJan 6, 2021
    Sep 30, 2020-$0.24N/AN/AN/AN/AN/AN/AN/ANov 2, 2020
    Jun 30, 2020-$1.02N/AN/AN/AN/AN/AN/AN/ASep 30, 2020
    Mar 31, 2020-$0.79N/AN/AN/AN/AN/AN/AN/AJun 29, 2020
    Dec 31, 2019-$0.79N/AN/AN/AN/AN/AN/AN/AMar 30, 2020
    Jun 30, 2019-$0.97N/AN/AN/AN/AN/AN/AN/ASep 30, 2019
    Mar 31, 2019-$0.84N/AN/AN/AN/AN/AN/AN/AJun 29, 2019
    Dec 31, 2018-$0.84N/AN/AN/AN/AN/AN/AN/AMar 30, 2019
    Last 31 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$3.35, after -$3.03 the year before. It was -$0.84 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$3.35N/A
    Dec 31, 2024-$3.03N/A
    Dec 31, 2023-$3.69-255.7%
    Dec 31, 2022$2.37N/A
    Dec 31, 2021-$1.60N/A
    Dec 31, 2020-$4.91N/A
    Dec 31, 2019-$2.60N/A
    Dec 31, 2018-$0.84N/A

    Frequently Asked Questions About CGEM

    When is Cullinan Oncology LLC's next earnings date?

    Cullinan Oncology LLC's next earnings report is expected for Mar 8, 2027.

    Did CGEM beat earnings estimates last quarter?

    Yes. Cullinan Oncology LLC reported EPS of -$0.74 for the quarter ended Sep 30, 2026, above the -$0.79 estimate, a 6.33% surprise.

    What EPS do analysts expect from CGEM next quarter?

    The consensus EPS estimate for Cullinan Oncology LLC for the quarter ending Dec 31, 2026 is -$0.84 from 15 analysts, with estimates from -$1.14 to -$0.38.

    How often does CGEM beat earnings estimates?

    Cullinan Oncology LLC beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +1.21%.